Search - tctmd.com

Displaying 1 - 20 of 88

Sort: Relevancy | Date

Presentation TCT 2025

TCT 529: Clinical Outcomes after Scoring-balloon and Sirolimus-eluting Balloon Strategy in Diffuse Small-vessel Coronary Artery Disease (SCA-DEB Study)

Presenter: Valery Ljubenov Gelev

October 28, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Daily News

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

Yael L. Maxwell

May 05, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

Presentation TCT 2024

TCT 434: Clinical Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Presenter: Kiril Karamfiloff

October 28, 2024

Presentation TCT 2024

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

Presenter: Hesham Refaat

October 28, 2024

Presentation TCT 2024

TCT 444: Angiographic Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Presenter: Kiril Karamfiloff

October 28, 2024

Presentation TCT 2024

Impact of Small or Non-Small Vessel Disease to Drug-Coated Balloon Angioplasty for the Treatment of De Novo Coronary Artery Lesions: Insights From the REC-CAGEFREE I Trial

Presenter: Patrick Serruys

October 27, 2024

News Conference News ESC 2024

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

Todd Neale

September 09, 2024

News Conference News ESOC 2024

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

Todd Neale

May 16, 2024

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Daily News

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

Michael O'Riordan

September 21, 2023

News Industry News

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

June 01, 2023

News Conference News EuroPCR 2023

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Michael O'Riordan

May 18, 2023

News Industry News

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

May 01, 2023

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

Presentation TCT 2022

TCT 130: Drug-Coated Balloons for the Treatment of Small Vessel Coronary Artery Disease: Primary Outcomes of a Multicenter Randomized Non-Inferiority Trial

Presenter: Paul Underwood

September 18, 2022

Advertisement

TCT 529: Clinical Outcomes after Scoring-balloon and Sirolimus-eluting Balloon Strategy in Diffuse Small-vessel Coronary Artery Disease (SCA-DEB Study)

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Top Coronary Artery Disease News in 2024

TCT 434: Clinical Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

TCT 444: Angiographic Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Impact of Small or Non-Small Vessel Disease to Drug-Coated Balloon Angioplasty for the Treatment of De Novo Coronary Artery Lesions: Insights From the REC-CAGEFREE I Trial

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

TCT 130: Drug-Coated Balloons for the Treatment of Small Vessel Coronary Artery Disease: Primary Outcomes of a Multicenter Randomized Non-Inferiority Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content